New! Sign up for our free email newsletter.

Brain Tumor News

November 20, 2024

Top Headlines

 

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells are too varied, and the microenvironment is too tumor-friendly. ...
Researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab, forces brain cancer cells to display targets for the immune system to ...
Researchers have uncovered new targets that could be the key to effectively treating glioblastoma, a lethal type of brain cancer. These targets were identified through a screen for genetic ...
Research provides evidence that a drug used to slow the progression of the disease ALS shows promise in suppressing the self-renewing cancerous stem cells that challenge the present standards of care for these lethal grade 4 brain ...

Latest Headlines

updated 10:46pm EST

Earlier Headlines

 

Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like cells (GSCs) both in vitro and in vivo, according ...

Glioblastomas are highly aggressive, usually incurable brain tumors. If all therapeutic options are exhausted, patients have an average life expectancy of less than two years. Now researchers have ...

Scientists have discovered that electrical currents may make Natural Killer (NK) cells -- our very own cancer-killing immune cells -- even better killers, which could have significant implications ...

A team of researchers has discovered that the tumor suppressor protein Prostate apoptosis response-4 (Par-4) can cause a unique type of cell death called ferroptosis in human glioblastoma -- the most ...

Burst sine wave electroporation was found to cause less damage to cells and tissue but more disruption to the blood-brain ...

A team of researchers has identified and located a population of stem-like cells that initiates and maintains Group 3 medulloblastoma (Gr3-MB) in the developing brain. Gr3-MB is one of the most ...

A new approach to treating the most malignant type of brain cancer -- glioblastoma -- has shown strong promise in pre-clinical settings, raising hopes of increasing current average survival rates ...

Researchers have discovered a new potential drug target for the lethal wasting disease known as cancer cachexia. Their findings illustrate that even small groups of neurons in the brain can have an ...

A new study shows that already a 30-minute exercise can increase the proportion of tumor-killing white blood cells in the bloodstream of breast cancer ...

When low doses of cancer drugs are administered continuously near malignant brain tumors using so-called iontronic technology, cancer cell growth drastically decreases. Researchers demonstrated this ...

Researchers are one step closer to understanding how pediatric DIPG tumors ...

A study has identified a biological mechanism that could lead to more effective treatments for breast cancer that has metastasized to the ...

In a major advance for the treatment of the deadly brain cancer glioblastoma, scientists used ultrasound technology to penetrate the blood-brain barrier and provide a small dose of a chemotherapy and ...

Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study, researchers report on a new surgical platform ...

For many patients with a deadly type of brain cancer called glioblastoma, chemotherapy resistance is a big problem. But now, researchers may have moved a step closer to a ...

Scientists have discovered how glioblastoma evades the immune system by inducing pro-tumor macrophages via a glucose based epigenetic ...

An mRNA cancer vaccine quickly reprogrammed the immune system to attack the most aggressive type of brain tumor in a first-ever human clinical ...

Scientists are developing and validating a patent-pending novel immunotherapy to be used against glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 ...

Targeting two brain tumor-associated proteins -- rather than one -- with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent glioblastoma (GBM), ...

Scientists have developed a new approach using the Zika virus to destroy brain cancer cells and inhibit tumor growth, while sparing healthy ...

Monday, August 12, 2024

Wednesday, July 31, 2024

Thursday, July 25, 2024

Tuesday, July 23, 2024

Wednesday, July 17, 2024

Tuesday, July 9, 2024

Monday, July 8, 2024

Wednesday, July 3, 2024

Wednesday, June 19, 2024

Thursday, June 13, 2024

Friday, June 7, 2024

Thursday, June 6, 2024

Thursday, May 30, 2024

Monday, May 20, 2024

Friday, May 3, 2024

Wednesday, May 1, 2024

Monday, April 22, 2024

Wednesday, March 13, 2024

Friday, March 8, 2024

Thursday, February 29, 2024

Thursday, February 15, 2024

Monday, January 22, 2024

Wednesday, January 3, 2024

Tuesday, December 12, 2023

Wednesday, November 29, 2023

Monday, November 27, 2023

Tuesday, November 21, 2023

Tuesday, November 14, 2023

Tuesday, October 31, 2023

Friday, October 27, 2023

Tuesday, October 17, 2023

Thursday, October 12, 2023

Wednesday, October 4, 2023

Thursday, September 28, 2023

Thursday, September 21, 2023

Thursday, September 14, 2023

Wednesday, September 6, 2023

Friday, September 1, 2023

Friday, August 11, 2023

Thursday, July 13, 2023

Friday, July 7, 2023

Wednesday, July 5, 2023

Monday, July 3, 2023

Thursday, June 15, 2023

Wednesday, June 14, 2023

Monday, June 12, 2023

Monday, June 5, 2023

Wednesday, May 31, 2023

Friday, May 12, 2023

Thursday, May 4, 2023

Monday, April 24, 2023

Friday, April 7, 2023

Thursday, March 23, 2023

Thursday, March 2, 2023

Friday, February 24, 2023

Tuesday, January 31, 2023

Wednesday, January 4, 2023

Thursday, December 22, 2022

Wednesday, December 21, 2022

Wednesday, November 30, 2022

Tuesday, November 29, 2022

Tuesday, November 15, 2022

Thursday, November 10, 2022

Tuesday, November 1, 2022

Wednesday, October 19, 2022

Tuesday, October 11, 2022

Friday, October 7, 2022

Thursday, October 6, 2022

Wednesday, September 28, 2022

Thursday, September 1, 2022

Monday, August 22, 2022

Tuesday, August 9, 2022

Monday, August 1, 2022

Thursday, July 28, 2022

Friday, July 15, 2022

Monday, July 11, 2022

Tuesday, June 28, 2022

Wednesday, June 22, 2022

Thursday, June 9, 2022

Thursday, May 26, 2022

Thursday, May 19, 2022

Wednesday, May 11, 2022

Monday, May 9, 2022

Monday, April 11, 2022

Tuesday, April 5, 2022

Monday, March 21, 2022

Friday, March 18, 2022

Tuesday, March 15, 2022

Tuesday, February 8, 2022

Monday, January 31, 2022

Friday, January 28, 2022

Wednesday, January 26, 2022

Tuesday, January 18, 2022

Wednesday, January 5, 2022